Solutions for gene therapy using a deeper analytical characterization of AAV vector development
April 14, 2020
Gene therapy—a type of DNA-based medicine that utilizes a virus to insert a healthy gene into cells to replace a mutated, disease-causing variant has emerged as one of the most promising medical treatments. While great advances and successfully launched treatments are available, there is still a lot of work that needs to be done to better characterize and further optimize viral vectors.
We share examples of using Prometheus to precisely monitor and distinguish unfolding and aggregation behavior of different adeno-associated virus (AAV) serotypes. We will show how concentration, buffer formulation and various stresses influence the stability of viral particles. Together, these results enable scientists to screen, identify, characterize and select the top AAV candidates that can be developed into novel gene therapies with the greatest potency and highest efficacy.
Molecular tools to study viral infectious diseases
Pandemics have affected human society throughout history, but with the current pandemic happening today, re...
Happy proteins make happy researchers, and how Tycho helps with that
How do you usually know whether your protein is happy? Even if you’re already using a portfolio of techniqu...
Sign up to receive the latest NanoTemper news, product updates, event announcements and more